AKAN
Akanda Corp
NASDAQ: AKAN · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$25.99
+48.60% today
Updated 2026-04-29
Market cap
$13.89M
P/E ratio
0.04
P/S ratio
16.60x
EPS (TTM)
$696.80
Dividend yield
—
52W range
$2 – $121
Volume
2.1M
Akanda Corp (AKAN) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | $-642328.00 | $-1.35M | $-6.56M | $-11.47M | $-1.50M | $-3.98M |
| Capital expenditures | $685922.00 | $439137.00 | $576472.00 | $310946.00 | $1502.00 | $2.10M |
| Depreciation | — | — | — | — | — | — |
| Stock-based comp | — | — | $0.00 | $559225.00 | $1.25M | — |
| Free cash flow | $-1.33M | $-1.79M | $-7.13M | $-11.78M | $-1.50M | $-6.08M |
| Investing cash flow | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — |